Review article · 2012 · Open access

Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

David J. Newman, Gordon M. L. Cragg

Journal of Natural Products, 75(3), 311–335 · Published 8 February 2012 · DOI 10.1021/np200906s

Read the free full textView at the publisherCite this paper

In brief

“Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010” is a 2012 review article by David J. Newman and Gordon M. L. Cragg, published in Journal of Natural Products. OpenAlex counts 4,801 citations as of 15 November 2026, which puts it in the top 1% of works published in 2012 by citations. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
4,801
Most cited in
2017 (432)
Field-weighted impact
31.39
References
125
Authors
2

Abstract

This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007. In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from January 1, 1981, to December 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2010 for all approved antitumor drugs worldwide. We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations. From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small molecules, 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compound approved as a drug in this 30-year time frame. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Newman, D. J., & Cragg, G. M. L. (2012). Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. Journal of Natural Products, 75(3), 311–335. https://doi.org/10.1021/np200906s

MLA 9

Newman, David J., and Gordon M. L. Cragg. “Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010.” Journal of Natural Products, vol. 75, no. 3, 2012, pp. 311–335. https://doi.org/10.1021/np200906s.

Chicago

Newman, David J. and Gordon M. L. Cragg. 2012. “Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010.” Journal of Natural Products 75 (3): 311–335. https://doi.org/10.1021/np200906s.

Harvard

Newman, D. J. and Cragg, G. M. L. (2012) ‘Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010’, Journal of Natural Products, 75(3), pp. 311–335. doi:10.1021/np200906s.

IEEE

D. J. Newman and G. M. L. Cragg, “Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010,” Journal of Natural Products, vol. 75, no. 3, pp. 311–335, 2012, doi: 10.1021/np200906s.

BibTeX

@article{newman2012natural,
  title     = {{Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010}},
  author    = {Newman, David J. and Cragg, Gordon M. L.},
  journal   = {Journal of Natural Products},
  year      = {2012},
  volume    = {75},
  number    = {3},
  pages     = {311--335},
  doi       = {10.1021/np200906s},
  url       = {https://doi.org/10.1021/np200906s}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
2017432432
2018328328
2019340340
2020356356
2021320320
2022257257
2023223223
2024217217
2025157157
20268989

Its field-weighted citation impact is 31.39: it has been cited 31.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis

  • natural products
  • drug discovery
  • approved drugs
  • anticancer agents
  • combinatorial chemistry
  • anti-infective agents
  • microbial natural products
  • host-microbe interactions

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Newman, D. J., & Cragg, G. M. L. (2012). Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. Journal of Natural Products, 75(3), 311–335. https://doi.org/10.1021/np200906s

How many times has this paper been cited?

4,801 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Europe PMC (PubMed Central).

Who wrote this paper?

David J. Newman, Gordon M. L. Cragg.

What is the DOI of this paper?

10.1021/np200906s. The permanent link is https://doi.org/10.1021/np200906s.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.